
Adrienne Rivlin, Partner, L.E.K. Consulting
Advertisement

Dr. Adrienne Rivlin is a partner in L.E.K.’s Healthcare practice, based in the London office. She advises private and public sector organisations across the pharmaceutical, biotech, medical device and consumer healthcare sectors on their critical commercial challenges, including corporate and portfolio strategy development; product launch; pricing and market access; clinical governance structures and processes; and commercial and regulatory due diligence.
Email: a.rivlin@lek.com
Articles by Adrienne Rivlin, Partner, L.E.K. Consulting

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK
2
When Foreign Investments in Pharma and Biotech Become a National Security Concern
3
Addressing Launch Drift to Optimize Product Launches
4
What FDA's Peptide Decision Means for the Industry
5